EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanoparticle-based antifungal therapies innovations mechanisms and future prospects

Qinglin Wu, Fulan Cen, Ying Xie, Xianjia Ning, Jinghua Wang, Zhenghao Lin, Jia Huang

PeerJ · 08.04.2025 · 13 · e19199

DOI: 10.7717/peerj.19199 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PeerJ, online erschienen am 08.04.2025. Verfasst von Qinglin Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, Shenzhen Third People's Hospital and the Second Hospital Affiliated with the Southern University of Science and Te…. Hauptthemen laut MEDLINE: Antifungal Agents, Mycoses, Nanoparticles. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen High-level Hospital Construction Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fungal infections present an increasing global health challenge, with a substantial annual mortality rate of 1.6 million deaths each year in certain situations. The emergence of antifungal resistance has further complicated treatment strategies, underscoring the urgent need for novel therapeutic approaches. This review explores recent advances in nanoparticle-based therapies targeting fungal infections, emphasizing their unique potential to enhance drug solubility, bioavailability, and targeted delivery. Nanoparticles offer the ability to penetrate biological barriers, improve drug stability, and act as direct antifungal agents by disrupting fungal cell walls and generating reactive oxygen species. Despite their promising applications, challenges such as potential toxicity, scalability of production, and the need for controlled drug release remain. Future research should focus on optimizing nanoparticle properties, evaluating long-term safety profiles, developing environmentally sustainable synthesis methods, and exploring synergistic approaches with existing antifungal drugs. Nanotechnology offers a transformative opportunity in the management of fungal diseases, paving the way for more effective and targeted treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsMycosesNanoparticlesHumansDrug Delivery SystemsAnimals

Stichwörter der Autor:innen

Clinical challengesDrug resistanceFungal infectionsNanotechnology

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Intensive Care Unit, Shenzhen Third People's Hospital and the Second Hospital Affiliated with the Southern University of Science and Technology, Shenzhen, Guangdong Province, China.
  • Graduate School of Public Administration, Seoul National University, Seoul, Republic of South Korea.
  • Center of Clinical Epidemiology, Shenzhen Third People's Hospital and the Second Hospital Affiliated with the Southern University of Science and Technology, Shenzhen, Guangdong Province, China.

Förderung

  • Shenzhen High-level Hospital Construction Fund

Zitieren

APA

Wu, Q., Cen, F., Xie, Y., Ning, X., Wang, J., Lin, Z., & Huang, J. (2025). Nanoparticle-based antifungal therapies innovations mechanisms and future prospects. PeerJ, 13, e19199. https://doi.org/10.7717/peerj.19199

Vancouver

Wu Q, Cen F, Xie Y, Ning X, Wang J, Lin Z, et al. Nanoparticle-based antifungal therapies innovations mechanisms and future prospects. PeerJ. 2025;13:e19199. doi:10.7717/peerj.19199

BibTeX
@article{Wu2025,
  author = {Wu, Qinglin and Cen, Fulan and Xie, Ying and Ning, Xianjia and Wang, Jinghua and Lin, Zhenghao and Huang, Jia},
  title = {Nanoparticle-based antifungal therapies innovations mechanisms and future prospects},
  journal = {PeerJ},
  year = {2025},
  volume = {13},
  pages = {e19199},
  doi = {10.7717/peerj.19199}
}
Kostenlos starten →